The contribution of methionine to the stability of the Escherichia coli MetNIQ ABC transporter-substrate binding protein complex by Nguyen, Phong T. et al.
Biol. Chem. 2015; 396(9-10): 1127–1134
aPresent address: California Institute for Quantitative Biosciences 
(QB3), MC2522, San Francisco, CA 94158, USA
*Corresponding author: Douglas C. Rees, Division of Chemistry and 
Chemical Engineering 114-96, California Institute of Technology, 
Pasadena, CA 91125, USA; and Howard Hughes Medical Institute 
114-96, California Institute of Technology, Pasadena, CA 91125, USA, 
e-mail: dcrees@caltech.edu
Phong T. Nguyen, Qi Wen Li and Neena S. Kadaba: Division of 
Chemistry and Chemical Engineering 114-96, California Institute of 
Technology, Pasadena, CA 91125, USA
Jeffrey Y. Lai and Janet G. Yang: Division of Chemistry and Chemical 
Engineering 114-96, California Institute of Technology, Pasadena, 
CA 91125, USA; and Howard Hughes Medical Institute 114-96, 
California Institute of Technology, Pasadena, CA 91125, USA
Phong T. Nguyen, Qi Wen Li, Neena S. Kadabaa, Jeffrey Y. Lai, Janet G. Yang 
and Douglas C. Rees*
The contribution of methionine to the stability 
of the Escherichia coli MetNIQ ABC transporter-
substrate binding protein complex
Abstract: Despite the ubiquitous role of ATP-binding cas-
sette (ABC) importers in nutrient uptake, only the Escheri-
chia coli maltose and vitamin B12 ABC transporters have 
been structurally characterized in multiple conformations 
relevant to the alternating access transport mechanism. 
To complement our previous structure determination of 
the E. coli MetNI methionine importer in the inward facing 
conformation (Kadaba et al. (2008) Science 321, 250–253), 
we have explored conditions stabilizing the outward fac-
ing conformation. Using two variants, the Walker B E166Q 
mutation with ATP+EDTA to stabilize MetNI in the ATP-
bound conformation and the N229A variant of the binding 
protein MetQ, shown in this work to disrupt methionine 
binding, a high affinity MetNIQ complex was formed with 
a dissociation constant measured to be 27 nm. Using wild 
type MetQ containing a co-purified methionine (for which 
the crystal structure is reported at 1.6 Å resolution), the 
dissociation constant for complex formation with MetNI is 
measured to be ∼40-fold weaker, indicating that complex 
formation lowers the affinity of MetQ for methionine by 
this amount. Preparation of a stable MetNIQ complex is an 
essential step towards the crystallographic analysis of the 
outward facing conformation, a key intermediate in the 
uptake of methionine by this transport system.
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Introduction
Many different transporters are encoded in the genomes 
of microorganisms to accommodate the diversity of mol-
ecules they need to acquire from the environment. For 
example, ∼10% of the Escherichia coli genome has been 
classified as participants in transport processes, of which 
approximately half are ATP-binding cassette (ABC) trans-
porters (Blattner et al., 1997; Linton and Higgins, 1998). 
ABC transporters consist of four domains: two trans-
membrane domains (TMDs) that form the translocation 
pathway, and two nucleotide-binding domains (NBDs) 
that use the energy from ATP binding and hydrolysis to 
fuel transport (reviewed in Ames et  al., 1992; Higgins, 
1992; Holland et al., 2003; Locher, 2008; Oldham et al., 
2008; Rees et al., 2009). The transport mechanism utilizes 
an alternating access model (Widdas, 1952;  Jardetsky, 
1966) that involves the interconversion of two distinct 
conformations during the transport cycle, inward facing 
and outward facing, where the translocation pathway is 
open to the cytoplasm and periplasm, respectively. ABC 
importers require an additional component for transport, 
namely substrate-binding proteins (SBP), located in the 
periplasm of Gram-negative bacteria or tethered to the 
membrane in Gram-positive bacteria and archaea, to bind 
and deliver substrates to their cognate transporter (Ames 
et al., 1992; Wilkinson and Verschueren, 2003;  Berntsson 
et al., 2010). Structures of transporters in complex with 
their binding proteins (Hollenstein et  al., 2007; Hvorup 
et  al., 2007; Oldham et  al., 2007; Korkhov et  al., 2012) 
have been instrumental in defining basic features of 
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the transport cycle, including the two best structur-
ally characterized ABC importers, the Type I maltose 
uptake system, MalFGK2 (Oldham and Chen, 2011) and 
the Type II vitamin B12 uptake system, BtuCD (Korkhov 
et al., 2014). Despite the common nucleotide-dependent 
engine driving translocation, binding protein-transporter 
interactions can vary significantly, reflecting mechanis-
tic diversity between various ABC importers (Lewinson 
et al., 2010).
In this work, we focus on the E. coli high affinity 
methionine uptake system (Kadner, 1974), comprising 
the MetNI transporter and its cognate binding protein, 
MetQ (Gál et  al., 2002; Merlin et  al., 2002). Currently, 
only the inward facing conformational state of MetNI 
has been solved crystallographically (Kadaba et  al., 
2008; Johnson et  al., 2012). To build a comprehensive 
model for MetNI transport, we sought to identify condi-
tions under which a stable transporter-binding protein 
complex can form. A challenge in working with E.  coli 
MetNI is that while methionine is the transported 
ligand, it also functions as an allosteric effector inhib-
iting methionine uptake at sufficiently high intracellu-
lar concentrations (Kadner, 1975). This phenomenon of 
transinhibition is mediated by methionine functioning 
as a noncompetitive inhibitor of ATPase activity (Yang 
and Rees, 2015) by binding to a cytoplasmic regulatory 
domain of the ABC subunit MetN to stabilize MetNI in 
an inward facing conformation incapable of hydro-
lyzing ATP (Kadaba et  al., 2008; Johnson et  al., 2012). 
Further complicating the analysis is the observation 
of a  co-purifying methionine in crystal structures of 
 methionine-binding SBPs (Deka et  al., 2004; Williams 
et al., 2004; Yang et al., 2009; Yu et al., 2011), including 
the E. coli MetQ structure (Kadaba, 2008).
Here we demonstrate that formation of a high affin-
ity MetNIQ complex requires an ATP-bound state of 
MetNI and an unliganded form of MetQ. Preparation 
of this complex is facilitated by the identification of 
mutations in MetQ that abolish methionine binding. 
The influence of methionine on complex formation 
between ATP-stabilized MetNI and MetQ is quantitated 
by titrating fluorescently labeled MetQ with varying con-
centrations of MetNI. From these measurements, disso-
ciation constants of 1100±300 and 27±9 nm are found for 
methionine-bound and methionine-free MetQ, respec-
tively, establishing that ligand-free MetQ can form a 
stable complex with the ATP-bound form of MetNI. Our 
isolation of a stable MetNIQ complex is an essential step 
towards the crystallographic analysis of the outward 
facing conformation, a key intermediate in the uptake of 
methionine by this transporter.
Results and discussion
To better understand the mechanism of the methionine 
transport system, we sought to identify conditions under 
which the MetNI transporter forms a stable complex with 
the cognate periplasmic binding protein MetQ. Previ-
ous studies demonstrated that wild type MetNI and wild 
type MetQ interact weakly in the absence of nucleotide 
(Kd = 7.4 × 10-5 m) and a stable complex under these condi-
tions could not be detected by gel filtration chromatog-
raphy (Lewinson et  al., 2010). Based on studies of the 
maltose system (Chen et al., 2001), we hypothesized that 
the MetNI transporter binds MetQ with the highest affinity 
in an ATP-bound state. To maintain the ATP-bound state, 
an ATPase deficient form was generated by substitution of 
Glu 166 in the Walker B motif of MetN with Gln (E166Q), 
in combination with the use of the chelator EDTA with 
ATP to remove the catalytically essential Mg2+. Mutation 
of the Walker B Glu is commonly used to inhibit hydroly-
sis, but not binding, of ATP by ABC transporters (Moody 
et al., 2002). ATPase assays show that the E166Q mutation 
results in an ∼20-fold reduction in ATPase activity (data 
not shown). All subsequent experiments in this study 
were conducted using this mutant transporter, denoted 
E166Q MetNI, in the presence of saturating amounts of 
ATP+EDTA (1 mm ATP and 1 mm EDTA) to mimic the ATP-
bound state.
We first tested for complex formation by incubat-
ing E166Q MetNI with wild type MetQ and saturating 
amounts of ATP+EDTA at different ratios of transporter 
to binding protein (Figure 1A). Mixtures of either 1:1.25 
or 1:6 (MetNI: MetQ) were injected onto a gel filtration 
column (Figure 1A), and the peak fraction was analyzed 
by blue native PAGE (Figure 1B) (BN PAGE; Reisinger and 
Eichacker, 2006) to evaluate the extent of complex for-
mation. Despite an excess of MetQ, incomplete complex 
formation was observed in both cases, as established by 
the slight shift in the peaks of MetNI after incubation with 
its binding protein at different molar ratios (Figure 1A), 
shown by blue and green traces compared to that of MetNI 
alone (black trace). This finding is confirmed by the pres-
ence of two bands on BN PAGE (Figure 1B, lanes 2 and 3), 
the upper one corresponding to the MetNIQ complex and 
the lower one to free transporter by comparison to E166Q 
MetNI alone (Figure 1B, lane 1).
Wild type MetQ contains a co-purifying methionine 
identified in the crystal structures of MetQ homologs 
Staphylococcus aureus lipoprotein-9 (PDB entry 1P99, 
 Williams et  al., 2004), Treponema pallidum Tp32 (PDB 
entry 1XS5, Deka et  al., 2004), E. coli MetQ (Kadaba, 
2008), Neisseria meningitidis (PDB 3IR1, Yang et al., 2009), 
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structure and binding site for L-methionine are illustrated 
in Figure 2 for E. coli MetQ refined at 1.6 Å resolution 
(PDB entry 4YAH, see Methods). An extensive hydrogen 
bond/salt bridge network between protein side chains 
and the methionine α-amino and carboxyl groups 
likely  contributes to the tight binding of ligand to MetQ. 
Groups interacting with the α-carboxyl group of methio-
nine include the side chains of Arg144, Asn202, and a 
buried water, while the α-amino group interacts with 
the side chains of Glu42 and Thr204 and two buried 
waters.  Significantly, the side chain of Asn229 forms two 
hydrogen bonds (one each) to the α-amino and carboxyl 
groups of the L-methionine. The side chain of the bound 
 L-methionine fits in a pocket surrounded by the aromatic 
side chains of Tyr69, Phe86, His88, and Tyr91. Aromatic 
interactions with the methionine side chain are not 
uncommon (Pal and Chakrabarti, 2001), particularly the 
interaction observed with the ligand SD packed against 
the plane of His88 such that the CG-SD bond is oriented 
towards the NE2 atom of His88.
To evaluate the contribution of L-methionine binding 
to MetQ to the stability of the MetNIQ complex, it is nec-
essary to prepare ligand-free MetQ. While methionine 
can be removed from MetQ by an unfolding/refolding 
process (Deka et al., 2004), we developed an alternative 
approach of using alanine-scanning mutagenesis to iden-
tify MetQ mutants that disrupt the binding of L-methio-
nine. Residues in the MetQ binding pocket in contact with 
methionine were mutated to alanine (Figures 2B and 3), 
with the exception of Glu42 that was substituted with Gln 
(E42Q) because the E42A mutant aggregated. To test for 
 L-methionine binding, we unfolded MetQ in 6 m guanidine-
HCl to release any co-purified L-methionine (Deka et al., 
2004), and then refolded the protein in the presence of 
Vibrio vulnificus (PDB 3K2D, Yu et  al., 2011) and unpub-
lished structures with PDB entries 3TQW, 3UP9, 4EF1, 
4GOT, 4IB2, 4K3F, 4QHQ, 4QYM, and 4Q5T. The basic 
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Figure 1: Detection of MetNIQ complex formation.
(A) Size-exclusion chromatography for detection of complex 
formation. Reactions of E166Q MetNI (40 μm) and MetQ at the 
indicated molar ratios in the presence of 1 mm ATP and 1 mm EDTA 
were injected onto a size-exclusion column. Incomplete complex 
formation was shown by a slight shift in E166Q MetNI (EQ) peak 
after incubation with wt MetQ (wt) at different ratios, 1:1.25 (blue 
trace) and 1:6 (green trace) (MetNI:MetQ), compared to the peak 
of MetNI alone (black trace). Stable complex formation was shown 
by a distinct shift in E166Q MetNI (EQ) peak after incubation with 
N229A MetQ (NA) at a ratio of 1:1.25 (MetNI: MetQ) (red traces), com-
pared to the peak of MetNI alone (black traces). (B) BN PAGE of the 
highest A280 eluate peak from the size-exclusion chromatography 
shown in panel (A). The upper arrow corresponds to the MetNIQ 
complex band and the lower arrow to MetNI band. Lane 1: E166Q 
MetNI alone; lanes 2 and 3: wild type MetQ added to E166Q MetNI 
at different ratios, 1:1.25 and 1:6 (MetNI:MetQ); lane 4: N229A MetQ 
added to E166Q MetNI at 1:1.25 (MetNI:MetQ) ratio.
Figure 2: The crystal structure of E. coli L-methionine-bound MetQ.
(A) Ribbon diagram of L-methionine-bound E. coli MetQ. (B) The L-methionine-binding site in MetQ. The side chains of the interacting 
residues are colored green, and the L-methionine ligand is colored gold. Hydrogen bonds between the α-amino and carboxyl groups of 
L-methionine and surrounding MetQ residues are represented by yellow dashes.
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L-selenomethionine. Selenium content was measured by 
inductively coupled plasma mass spectrometry  (ICP-MS), 
and the molar ratio of selenium to MetQ was calculated 
(Figure 3). Mutation of Glu42 to Gln (E42Q) and Asn229 to 
Ala (N229A) significantly decreased the binding affinity of 
MetQ to selenomethionine, while substitutions at other 
residues had relatively little effect on selenomethionine 
binding. The E42Q and N229A MetQ mutants, identified in 
this screen as unable to bind selenomethionine (and pre-
sumably methionine), were then tested for complex for-
mation with E166Q MetNI in the presence of ATP+EDTA. 
The E42Q mutant was unable to form a complex with 
its cognate transporter (data not shown). When N229A 
MetQ was incubated with E166Q MetNI in the presence 
of ATP+EDTA, however, a stable complex formation was 
indicated by a distinct shift in the MetNI gel filtration peak 
after the reaction, shown by the red trace (Figure 1A). This 
stoichiometric complex formation was also observed by 
BN PAGE (Figure 1B, lane 4). This result contrasts with 
the mixture of free and complexed species observed when 
E166Q MetNI is incubated with wild type liganded MetQ 
under comparable conditions (Figure 1B, lanes 2 and 3). 
Based on these results, the N229A MetQ variant was used 
in this study to mimic methionine-free MetQ.
To quantify the binding affinity of E166Q MetNI for 
MetQ in either the bound or unliganded state, we meas-
ured the dissociation constants for complex formation 
from titration curves conducted with fluorescently labeled 
MetQ on a Monolith NT.115 Microscale Thermophoresis 
Instrument (NanoTemper Technologies GmbH). Wild type 
and N229A MetQ were labeled with Cy3-maleimide and 
titrated with varying concentrations of E166Q MetNI in the 
presence of ATP+EDTA. The fraction of MetQ in complex 
with E166Q MetNI was calculated from fluorescent inten-
sity values (see materials and methods). The affinity of 
L-methionine-bound wild type MetQ for E166Q MetNI was 
∼40-fold weaker than that for unliganded N229A MetQ to 
E166Q MetNI (Figure 4). The calculated Kd of 1100±300 nm 
for wild type MetQ represents a lower limit for the affin-
ity, as saturating amounts of E166Q MetNI were prone to 
aggregation. The Kd for N229A MetQ was determined to be 
27±9 nm. This difference in affinity is qualitatively consist-
ent with our gel filtration (Figure 1A) and BN PAGE results 
(Figure 1B).
We have identified conditions promoting stable 
complex formation between MetNI and MetQ through the 
use of two mutations (the E166Q variant in the Walker B 
motif of MetN that reduces ATP hydrolysis, and the N229A 
variant of MetQ that disrupts methionine binding) and 
the presence of ATP+EDTA to reduce the concentration of 
Mg2+ critical for ATP hydrolysis. These conditions should 
stabilize the ATP-bound form of MetNI, corresponding to 
the outward facing conformation of a Type I ABC trans-
porter (Oldham and Chen, 2011). An unexpected feature 
of the MetNI system is that the use of ligand-free MetQ 
resulted in stable complex formation, in contrast to the 
maltose transporter system where formation of a stable 
transporter-SBP complex required the presence of the 
transported substrate (Chen et  al., 2001; Oldham et  al., 
2007). In the absence of ATP, a ‘pre-translocation’ species 
has also been crystallized with substrate-loaded SBP and 
an inward facing conformation of the transporter for the 
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Figure 3: Screening for substrate-binding-deficient MetQ mutants.
Alanine-scanning mutants of MetQ were analyzed for selenium content by ICP-MS after exchange of native substrate with L-selenomethio-
nine (see text). The horizontal and vertical axes denote the MetQ mutations and fraction of MetQ bound by selenomethionine, respectively. 
Error bars represent the standard deviation of duplicate samples.
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transporter in nanodiscs with AMPPNP (Kd∼80  nm and 
∼400 nm in the absence or presence of maltose, respec-
tively; Bao and Duong, 2012). An additional complica-
tion with the MetNI transporter is that methionine is 
both a transported ligand and an allosteric inhibitor of 
transport, and these effects will need to be distinguished 
from the contributions of the liganded state of MetQ to 
the observed kinetics. The development of a detailed 
molecular transport mechanism will require analysis of 
conformational dynamics of the type recently described 
for the GlnPQ uptake system (Gouridis et al., 2015). The 
structural analysis of stable forms of ABC transporters 
such as the MetNIQ complex detailed here will provide 
crucial reference states for these future mechanistic 
studies.
Materials and methods
Cloning, expression and purification of MetQ
The metNIQ operon was amplified from E. coli K-12 genomic DNA and 
cloned into a zero blunt pCR-4 TOPO vector as described in (Kadaba 
et al., 2008). The metQ gene, lacking the stop codon, was subcloned 
using oligonucleotides that included NdeI and XhoI restriction-
enzyme sites, and then ligated into the pET21b(+) vector with a 
C-terminal 6 × -histidine tag. The cloned plasmids were expressed 
separately in E. coli BL21 (DE3) gold cells (EMD) at 37°C in Terrific 
Broth medium with 100 μg/ml ampicillin. The cells were induced 
at OD600 ∼4.0 with 0.4 mm IPTG for 2 h, then harvested and stored 
at -80°C.
For purification of mature MetQ, periplasmic extract was pre-
pared by resuspending 10 g of cell paste in 10 ml of 40% sucrose, 
10 mm Tris-HCl pH 7.5, and 1 mm EDTA, and stirred for 1 h at room 
temperature. The cells were then shocked by addition of 500 ml of 
ice-cold water. After stirring for 10 min, buffer components were 
added to a final concentration of 25 mm Tris pH 7.5, 150 mm NaCl, 
and 17 mm imidazole. The resulting suspension was then cen-
trifuged at 37 500 g for 30  min to remove all cellular debris from 
the periplasmic extract. MetQ was isolated from the periplasmic 
extract by immobilized metal ion affinity chromatography using 
a 5 ml Ni-NTA column (GE). The affinity column was washed with 
25 mm Tris pH 7.5, 150 mm NaCl, and 17 mm imidazole for 10 column 
volumes. Protein was then eluted from the column using 25 mm Tris 
pH 7.5, 100 mm NaCl and 150  mm imidazole. Peak fractions were 
dialyzed against 25 mm Tris pH 7.5 and 150 mm NaCl overnight, and 
then concentrated to 30 mg/ml using a 10kD MWCO concentrator 
(Millipore).
The full-length protein cloned for this work, including the signal 
sequence and the C-terminal 6 × -his tag, has the sequence:
 1 MAFKFKTFAAVGALIGSLALVGCGQDEKDPNHIKVGVIVGAEQQVAEVAQKVAKDKYGLD
 61 VELVTFNDYVLPNEALSKGDIDANAFQHKPYLDQQLKDRGYKLVAVGNTFVYPIAGYSKK
121 IKSLDELQDGSQVAVPNDPTNLGRSLLLLQKVGLIKLKDGVGLLPTVLDVVENPKNLKIV
181 ELEAPQLPRSLDDAQIALAVINTTYASQIGLTPAKDGIFVEDKESPYVNLIVTREDNKDA
241 ENVKKFVQAYQSDEVYEAANKVFNGGAVKGWLEHHHHHH
molybdate (Hollenstein et al., 2007) and maltose (Oldham 
and Chen, 2011) transporters. While the corresponding 
complex between liganded SBP and the methionine trans-
porter is substantially less stable [Kd∼7.5 × 10-5 m  (Lewinson 
et  al., 2010)] than the complex in the presence of ATP 
measured in this work (Kd∼10-6 m), at the protein con-
centrations (∼10-4 m) used in crystallization trials, perhaps 
this state of the MetNIQ complex could also be crystallized 
under appropriate conditions.
The role of transported ligand in complex formation 
is of great mechanistic interest. For complex formation 
between MetNI and MetQ, the difference in dissociation 
constants between unliganded (27 nm) and liganded 
(1100 nm) MetQ implies that the binding of methionine 
to MetQ in complex with MetNI is ∼40-fold weaker than 
the binding of methionine to MetQ alone. Energeti-
cally, this observation is consistent with a model where 
the SBP must release ligand for transport to occur. The 
detailed energetics will certainly depend on the trans-
porter and assay conditions; for example, while liganded 
maltose binding protein has been reported to more effi-
ciently stimulate ATP hydrolysis of maltose transporter 
reconstituted into proteoliposomes (Davidson et  al., 
1992), ligand-free maltose binding protein binds 5-fold 
more tightly than liganded binding protein to maltose 
0.8
0.6
0.4
0.2
0
-0.2
0.1 10 100 1000
E166Q MetNI (nM)
Fr
ac
tio
n 
bo
un
d
10 000
N229A MetQ
Wild type MetQ
100 0001
1
Figure 4: Dissociation constants between MetNI and MetQ.The 
affinity of MetNI for MetQ was measured by titration curves using 
fluorescently labeled MetQ in the presence or absence of bound 
methionine (wild type or N229A MetQ, respectively). All experi-
ments contained 1 mm ATP and 1 mm EDTA. 101 nm of Cy3-labeled 
wild type MetQ was titrated with 1.95 nm – 32 μm non-labeled 
E166Q MetNI (closed squares). 99 nm of Cy3-labeled N229A MetQ 
was titrated with 1.95 nm – 4 μm non-labeled MetNI E166Q (open 
circles). The dissociation constants calculated from these data for 
wild type (methionine-bound) and N229A (methionine-free) MetQ 
binding to E166Q MetNI are Kd = 1100±300 nm and 27±9 nm, respec-
tively. Error bars represent standard error from three independent 
measurements.
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The cleaved signal sequence is highlighted in bold, so that the puri-
fied protein used in this study consists of residues 17–279, of which 
residues 29–273 (underlined) are observed in the electron density.
Purification of MetNI
Purification of wild type and mutant E166Q MetNI was carried out as 
described (Johnson et al., 2012) with the one modification that buffer 
containing 20 mm TAPS pH 8.5, 100 mm NaCl and 0.025% DDM (with 
varying amounts of imidazole) was used in all purification steps (the 
original protocol used 250 mm NaCl and different detergents).
MetQ crystallization and structure determination
Crystallization conditions for MetQ were screened with varying con-
centrations of protein from 15 mg/ml to 60 mg/ml. Crystals were 
obtained using a hanging drop vapor diffusion method at 20°C, by 
mixing 1 μl of protein to 1 μl of the following well solution: 24% PEG 
4000, 4% PEG 400, 0.1 m sodium citrate pH 5.6, and 0.2 m ammo-
nium acetate at 30 mg/ml of protein, similar to the conditions origi-
nally described (Kadaba, 2008). Initial thin needle crystals appeared 
within a week but crystals were not large enough for data collection. 
Both microseeding and macroseeding were used to obtain larger 
crystals, reaching a final size of 0.5 × 0.2 × 0.1 mm3 in a week. The best 
crystal was obtained by macroseeding with a precipitant 20% PEG 
4000, 3% PEG 400, 0.1 m sodium citrate pH 5.6, and 0.2 m ammo-
nium acetate. Diffraction data to 1.6 Å resolution were collected at the 
Stanford Synchrotron Radiation Lightsource (SSRL) on Beamline 12-2. 
The data was processed using xia2 (Winter, 2010) with XDS  (Kabsch, 
2010), XSCALE, and AIMLESS (Evans, 2006), with data collection 
and processing statistics listed in Table 1. Molecular replacement 
was performed using Phenix (Adams et al., 2010) from the previously 
solved 1.8 Å resolution MetQ structure (Kadaba, 2008) that was in 
turn solved by molecular replacement from PDB entry 1P99 (Williams 
et  al., 2004), a Gly-Met-binding protein. The structure was refined 
with Phenix to 1.6 Å resolution to a final R/R-free of 0.154/0.183. Coor-
dinates and structure factors have been deposited in the Protein Data 
Bank of the Research Collaboratory for Structural Bioinformatics, 
with ID 4YAH.
Screening of substrate-binding deficient MetQ mutants
Individual residues located in the substrate-binding pocket of MetQ 
were substituted with alanine by site-directed mutagenesis using 
the Quickchange Mutagenesis kit (Stratagene), with the exception 
of Glu42, which was substituted with glutamine to avoid aggrega-
tion. To evaluate the binding ability of each mutant for substrate, 
L-methionine was exchanged with L-selenomethionine, and the 
amount of selenium was measured using inductively coupled plasma 
mass spectrometry (ICP-MS).
To exchange L-methionine with L-selenomethionine, individual 
MetQ mutants immobilized onto Ni-NTA columns were unfolded by 
washing with 12 column volumes of denaturing buffer containing 6 m 
guanidine-HCl, 25 mm Tris pH 7.5, 150 mm NaCl at the rate of 1.5 ml/
min to remove bound L-methionine. To refold MetQ, guanidine-HCl 
Table 1: Data processing and refinement statistics.
Data processing statistics   MetQ
 Space group   C2221
 Unit cell dimensions (a, b, c) (Å)  59.7, 87.4, 112.9
 Wavelength (Å)   1.00
 Resolution (Å)a   24.5–1.60 (1.64–1.60)
 Unique reflections   38 555
 Redundancy   4.1
 Completeness (%)   98.4 (96.1)
 I/σ   11.5 (1.11)
 Rmerge   0.07 (0.952)
Refinement statistics   PDB ID 4YAH
 Resolution (Å)a   24.5–1.60 (1.64–1.60)
 R-work   0.154 (0.360)
 R-free   0.183 (0.409)
 Average B factor (Å)   27.7
 RMSD bond length (Å)   0.008
 RMSD bond angle (°)   1.21
  Ramachandran plot (favored, 
allowed, outliers,%)
  98, 2, 0
aNumbers in parentheses represent data in the highest resolution 
shell.
was slowly removed by flowing renaturation buffer (2 mm L-sele-
nomethionine, 25 mm Tris pH 7.5, 150 mm NaCl) over the column at 
1 ml/min for 90 min. The column was further washed with 10 col-
umn volumes of renaturation buffer to ensure reloading of MetQ with 
L-selenomethionine. This was followed by 12 column volumes of 
wash buffer (25 mm Tris pH 7.5 and 150 mm NaCl) to remove unbound 
L-selenomethionine. Finally, MetQ was eluted in 25 mm Tris pH 7.5, 
150 mm NaCl, and 150 mm imidazole, and run over a size-exclusion 
column (Superdex 200 16/60, GE Healthcare) equilibrated in 25 mm 
Tris, pH 7.5 and 150 mm NaCl. The monodisperse peak was collected 
and concentrated to 20 mg/ml using an Amicon 10-kD MWCO con-
centrator (Millipore).
The amount of bound L-selenomethionine was measured by 
quantitation of the selenium content of acid-digested protein sam-
ples using ICP-MS. A final concentration of 0.1 μm of protein was 
digested with 2% trace metal grade nitric acid (Fluka) at 70°C over-
night. Samples were centrifuged at 30 000 g for 10 min using a bench 
top centrifuge to remove particulate matter. The supernatant was 
then diluted to a final volume of 5  ml in double distilled H2O and 
measured for Se78 with an HP 4500 ICP-MS instrument. L-selenom-
ethionine powder stock (Anatrace) was used to prepare standards. 
Each sample was measured in duplicate in two independent experi-
ments. Error bars represent standard deviation. Data were processed 
and graphed using Microsoft Excel and Sigmaplot 11.0, respectively.
Qualitative determination of complex formation
MetNI and MetQ concentrations were measured using a NanoDrop 
2000 Spectrophotometer (Thermo Scientific), according to their cal-
culated extinction coefficients for a 1 mg/ml solution at 280 nm of 
0.64 and 0.73, respectively. Complex formation was assessed by mix-
ing E166Q MetNI transporter and its cognate binding protein, MetQ, 
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at a molar ratio of 1:1.25 (MetNI: MetQ) in the presence of 1 mm ATP 
and 1 mm EDTA. The mixture, containing 40 μm MetNI, 50 μm MetQ, 
1 mm ATP, 1 mm EDTA, 20 mm TAPS pH 8.5, 100 mm NaCl, 0.025% 
DDM, and 5 mm β-mercaptoethanol, was incubated for 1 h at room 
temperature and ultracentrifuged at 200 000 g for 20 min to remove 
any aggregation. Samples were injected onto a Superdex S200 10/300 
sizing column (GE Healthcare) equilibrated with buffer containing 
20 mm TAPS pH 8.5, 100 mm NaCl, 0.5 mm ATP, 1 mm EDTA, 0.3% 
Cymal-5, and 5 mm β-mercaptoethanol. The absorbance reading at 
280  nm and the retention volume of the peak were used to follow 
complex formation. MetNIQ complex formation was verified by ana-
lyzing the highest peak by BN PAGE (Reisinger and Eichacker, 2006) 
using 4–20% Criterion gels (Bio-Rad). Two independent experiments 
were conducted per condition.
Measurement of MetNIQ complex dissociation constant
The E. coli MetQ sequence contains one cysteine residue at amino 
acid position 23. Purified wild type MetQ and N229A MetQ were 
labeled with Cy3-maleimide (GE Healthcare), according to the 
 manufacturer’s instructions, in buffer containing 25 mm Tris 
pH 7.5, 150 mm NaCl, and 10 mm TCEP pH 7.5. Unreacted dye was 
removed using a Superdex 200 10/300 GL column (GE Healthcare) 
equilibrated with the aforementioned buffer condition. The label 
to protein ratio was determined using a NanoDrop 2000 Spectro-
photometer (Thermo Scientific) at 550 and 280 nm, and a labeling 
efficiency of 10% was calculated. Fluorescence measurements were 
performed on a Monolith NT.115 Instrument (NanoTemper Technolo-
gies GmbH) at 25°C using standard capillaries. Varying concentra-
tions (ranging from 1.95 nm to 32 μm) of unlabeled E166Q MetNI 
in ATP buffer (1 mm ATP, 1 mm EDTA, 20 mm TAPS pH 8.5, 100 mm 
NaCl, and 0.3% Cymal-5) were titrated against a constant concentra-
tion of MetQ (101 nm of wild type MetQ or 99 nm of N229A MetQ). 
 Fluorescent intensity as a function of E166Q MetNI concentration 
was normalized to fraction bound by averaging the intensity values 
for the lowest three concentrations of E166Q MetNI per experiment. 
This background intensity was subtracted from all concentrations to 
yield corrected intensity values. The corrected intensity values were 
then divided by the corrected intensity at the highest concentra-
tion of E166Q MetNI to normalize intensity values to fraction bound 
values. Dissociation constants for wild type MetQ or N229A MetQ 
binding to E166Q MetNI were calculated using the Kd Fit function of 
the NanoTemper Analysis 1.5.41 software. Three independent MST 
measurements per condition were conducted, and error bars repre-
sent standard error of the mean.
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